6Toussirot E,Wendling D.Current guidelines for the drug treatment of ankylosing spondylitis.Br J Rheumatol,1996,35(8):767.
7Huang F,Cu J,Braun J,et al.Identifying the targets of thalidomide And anti-TNF anribody treatments in ankylosing spondylitis.Arthritis Rheum,2000,43(9):396.
8Brau J,Bollow M,Neure L,et al.Use of immunohistological and in situ hybridization technique in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis.Arthritis Rheum,1995,38:499.
3张乃铮 Wigley R 等.中国风湿性疾病的流行情况调查[J].中华风湿病学杂志,1997,1(1):31-31.
4赵伟 黄烽.单核因子与脊柱关节病[J].中华风湿病学杂志,2000,4(4):248-248.
5Huang F, Gu J, Zhao W, et al. One-year open-hbel trial of thalidomide in ankylosing spondylitis. Arthritis Rheum (Arthritis Care Res), 2002,47: 249-254.
6Davis J, Huang F, Maksymowych WP. New therapies for ankylosing spondylitis: etanercept, thalidomide and pamidronate. Rheum Dis Clin North Am, 2003,29 : 501-517.
7Huang F, Wei J, Breban M. Thalidomide in ankylosing spondylitis.Clin Exp Rheumatol, 2002,20: S158-161.
8Huang F, Gu J, Zhao W, et al. Therapeutic effect and molecular targets of thalidomide in refractory ankylosing spondylitis. Arthritis Rheum,2001,44 : S275.
9Gorman J, Sack K, Davis J. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α. N Engl J Med, 2002,346:1349-1356.
10Braun J, Brandt J, Listing J, et al. Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicentre trial. Lancet, 2002,359:1187.
